ORAL ABX464 QD IS SAFE AND EFFICACIOUS DURING 52 WEEKS OPEN LABEL MAINTENANCE FOLLOWING A PLACEBO CONTROLLED INDUCTION STUDY IN ULCERATIVE COLITIS PATIENTS

Severine Vermeire  1     Xavier Hebuterne  2     Piotr Napora  3     Maria Wisniewska Jarosinska  4     Gyula G. Kiss  5     Arnaud Bourreille     Przemyslaw Zajac     Josianne Nitcheu     Paul GINESTE     Hartmut Ehrlich     Jean-Marc Steens    
1 University Hospital Leuven - Dept. of Gastroenterology, University Hospital Leuven; Leuven/BE - Dept,Leuven,Belgium
2 Hospital Archet 2, Nice,Nice,France
3 Piotr Napora Centrum Badan Klinicznych Lekarze Sp.p,Wraclow,Poland
4 Department of Gastroenterology Mediacal University of Lodz,Lodz,Poland
5 Hajdú-Bihar Megyei Önko

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing